Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Lansigan

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Oncology (Williston Park, N.Y.)|June 24, 2010
Navigating the treatment choices for mycosis fungoidesFrederick Lansigan
Cureus|July 28, 2020
Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell LymphomaClifford B Locke, Frederick Lansigan
Journal of Cutaneous Pathology|September 7, 2020
Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosisRobert E LeBlanc, Frederick Lansigan
JAMA Oncology|December 9, 2021
Solving the Equation of Structural Inequities in the Oncology WorkforceFrederick Lansigan, Charles R Thomas
Drugs|February 20, 2010
Current and emerging treatment strategies for cutaneous T-cell lymphomaFrederick Lansigan, Francine M Foss
Cancer Management and Research|December 29, 2010
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaFrederick Lansigan, Diane M Stearns, Francine Foss
Hematology/Oncology Clinics of North America|October 29, 2008
Cutaneous T-cell lymphomaFrederick Lansigan, Jaehyuk Choi, Francine M Foss
Rheumatology (Oxford, England)|December 15, 2010
Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13Frederick Lansigan, Iris Isufi, Clement E Tagoe
JAMA Oncology|August 25, 2022
Race and Ethnicity-Conscious Clinical Research Best PracticesOdeth Barrett-Campbell, Maya DeGroote, Frederick Lansigan
Frontiers in Oncology|November 9, 2023
Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidoteAditya Sharma, Philip Benoit, Frederick Lansigan, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|June 24, 2010
Navigating the treatment choices for mycosis fungoidesFrederick Lansigan
Cureus|July 28, 2020
Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell LymphomaClifford B Locke, Frederick Lansigan
Journal of Cutaneous Pathology|September 7, 2020
Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosisRobert E LeBlanc, Frederick Lansigan
JAMA Oncology|December 9, 2021
Solving the Equation of Structural Inequities in the Oncology WorkforceFrederick Lansigan, Charles R Thomas
Drugs|February 20, 2010
Current and emerging treatment strategies for cutaneous T-cell lymphomaFrederick Lansigan, Francine M Foss
Cancer Management and Research|December 29, 2010
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaFrederick Lansigan, Diane M Stearns, Francine Foss
Hematology/Oncology Clinics of North America|October 29, 2008
Cutaneous T-cell lymphomaFrederick Lansigan, Jaehyuk Choi, Francine M Foss
Rheumatology (Oxford, England)|December 15, 2010
Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13Frederick Lansigan, Iris Isufi, Clement E Tagoe
JAMA Oncology|August 25, 2022
Race and Ethnicity-Conscious Clinical Research Best PracticesOdeth Barrett-Campbell, Maya DeGroote, Frederick Lansigan
Frontiers in Oncology|November 9, 2023
Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidoteAditya Sharma, Philip Benoit, Frederick Lansigan, et al.
Pageof 9